Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
G Chir ; 37(4): 167-170, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27938534

RESUMEN

Acute chylous peritonitis is defined as the onset of acute abdomen findings due to abrupt chylous fluid accumulation in the peritoneal space. A correct diagnosis of this condition is seldom made preoperatively. The optimal management of true chylous pancreatitis depends upon the underlying etiology. Thorough lavage of the abdomen and adequate drainage has proven to be an excellent treatment modality for acute chylous peritonitis, since resolution of chylous ascites usually occurs within the next few days. However, conservative treatment may be appropriate in selected cases. We present a case report and a brief review of the literature.


Asunto(s)
Ascitis Quilosa/complicaciones , Ascitis Quilosa/terapia , Drenaje , Pancreatitis/complicaciones , Pancreatitis/terapia , Irrigación Terapéutica , Dolor Abdominal/etiología , Adulto , Ascitis Quilosa/diagnóstico , Drenaje/métodos , Femenino , Humanos , Náusea/etiología , Pancreatitis/diagnóstico , Irrigación Terapéutica/métodos , Resultado del Tratamiento , Vómitos/etiología
3.
J Oncol ; 2019: 5879616, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31827511

RESUMEN

The recent introduction of the "precision medicine" concept in oncology pushed cancer research to focus on dynamic measurable biomarkers able to predict responses to novel anticancer therapies in order to improve clinical outcomes. Recently, the involvement of extracellular vesicles (EVs) in cancer pathophysiology has been described, and given their release from all cell types under specific stimuli, EVs have also been proposed as potential biomarkers in cancer. Among the techniques used to study EVs, flow cytometry has a high clinical potential. Here, we have applied a recently developed and simplified flow cytometry method for circulating EV enumeration, subtyping, and isolation from a large cohort of metastatic and locally advanced nonhaematological cancer patients (N = 106); samples from gender- and age-matched healthy volunteers were also analysed. A large spectrum of cancer-related markers was used to analyse differences in terms of peripheral blood circulating EV phenotypes between patients and healthy volunteers, as well as their correlation to clinical outcomes. Finally, EVs from patients and controls were isolated by fluorescence-activated cell sorting, and their protein cargoes were analysed by proteomics. Results demonstrated that EV counts were significantly higher in cancer patients than in healthy volunteers, as previously reported. More interestingly, results also demonstrated that cancer patients presented higher concentrations of circulating CD31+ endothelial-derived and tumour cancer stem cell-derived CD133 + CD326- EVs, when compared to healthy volunteers. Furthermore, higher levels of CD133 + CD326- EVs showed a significant correlation with a poor overall survival. Additionally, proteomics analysis of EV cargoes demonstrated disparities in terms of protein content and function between circulating EVs in cancer patients and healthy controls. Overall, our data strongly suggest that blood circulating cancer stem cell-derived EVs may have a role as a diagnostic and prognostic biomarker in cancer.

4.
Mol Biosyst ; 12(1): 219-32, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26588820

RESUMEN

Classical Hodgkin lymphoma (cHL) is a malignancy with complex pathogenesis. The hallmark of the disease is the presence of large mononucleated Hodgkin and bi- or multinucleated Reed/Sternberg (H/RS) cells. The origin of HRS cells in cHL is controversial as these cells show the coexpression of markers of several lineages. Using a proteomic approach, we compared the protein expression profile of cHL models of T- and B-cell derivation to find proteins differentially expressed in these cell lines. A total of 67 proteins were found differentially expressed between the two cell lines including metabolic proteins and proteins involved in the regulation of the cytoskeleton and/or cell migration, which were further validated by western blotting. Additionally, the expression of selected B- and T-cell antigens was also assessed by flow cytometry to reveal significant differences in the expression of different surface markers. Bioinformatics analysis was then applied to our dataset to find enriched pathways and networks, and to identify possible key regulators. In the present study, a proteomic approach was used to compare the protein expression profiles of two cHL cell lines. The identified proteins and/or networks, many of which not previously related to cHL, may be important to better define the pathogenesis of the disease, to identify novel diagnostic markers, and to design new therapeutic strategies.


Asunto(s)
Enfermedad de Hodgkin/metabolismo , Proteoma , Proteómica , Línea Celular Tumoral , Citometría de Flujo , Regulación Neoplásica de la Expresión Génica , Enfermedad de Hodgkin/genética , Humanos , Modelos Biológicos , Mapeo de Interacción de Proteínas , Mapas de Interacción de Proteínas , Proteómica/métodos
5.
J Comp Pathol ; 132(1): 96-100, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15629484

RESUMEN

Ocular squamous cell carcinoma (OSCC) is a well-characterized tumour occurring spontaneously in cattle and other mammalian species but not previously reported in the goat. This report describes the histological features of well-differentiated OSCCs in twin goats. Biomolecular investigations led to the identification of Papillomavirus-related DNA sequences within the neoplastic ocular parenchyma of both animals, but immunohistochemical and ultrastructural studies failed to demonstrate viral particles. A putative role of Papillomavirus in the aetiology of OSCC is discussed, together with other possible causative factors.


Asunto(s)
Carcinoma de Células Escamosas/veterinaria , Neoplasias del Ojo/veterinaria , Enfermedades de las Cabras , Infecciones por Papillomavirus/veterinaria , Animales , Carcinoma de Células Escamosas/etiología , Carcinoma de Células Escamosas/patología , ADN Viral/análisis , Neoplasias del Ojo/etiología , Neoplasias del Ojo/patología , Femenino , Cabras , Técnicas para Inmunoenzimas/veterinaria , Masculino , Papillomaviridae/genética , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/complicaciones , Infecciones por Papillomavirus/patología , Gemelos
6.
Int J Immunopathol Pharmacol ; 16(3): 269-76, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14611731

RESUMEN

The distribution of DNA of BK and JC human polyomaviruses (BKV and JCV) was investigated in samples from autopsies of different organs in 2 groups of patients: Human Immunodeficiency Virus -1 (HIV) positive and negative. Samples from various organs were analysed by a nested polymerase chain reaction (PCR) for the non-coding control and for the VP1 regions of both viruses. The results obtained showed that BKV DNA was present in both males and females with a higher prevalence in HIV-positive subject samples (spleen: 33%; kidney: 44%; brain: 22%, uterine cervix:100%; prostatic urethra: 50%). In prostatic urethra samples of HIV-positive subjects, the JCV DNA was revealed in a low percentage (33%), while it was not found at all in uterine cervix samples of both groups. The varying presence of BK and JC viral DNA in the different organs seems to reflect the different pathogenetic attitude of these viruses. JCV was mainly present in the brain (55%), confirming its typical neurotropism and its etiological role in neurological disorders found in immunodeficient patients. BKV, on the other hand, was mainly present in the kidney (44%) and in genital organs (uterine cervix: 100%; prostatic urethra: 50%) with the latter finding favouring the hypothesis of a possible sexual transmission of BKV. Furthermore, our results confirm the crucial role of the immune system in the persistence of human polyomaviruses in the host.


Asunto(s)
Virus BK/genética , Seronegatividad para VIH/genética , Seropositividad para VIH/genética , VIH-1/genética , Virus JC/genética , Análisis de Secuencia de ADN , Adulto , Anciano , Virus BK/química , Virus BK/aislamiento & purificación , Química Encefálica/genética , Cuello del Útero/química , Cuello del Útero/virología , Femenino , Seropositividad para VIH/mortalidad , Seropositividad para VIH/patología , Seropositividad para VIH/virología , VIH-1/química , VIH-1/aislamiento & purificación , Humanos , Virus JC/química , Virus JC/aislamiento & purificación , Riñón/química , Riñón/virología , Masculino , Persona de Mediana Edad , Especificidad de Órganos/genética , Análisis de Secuencia de ADN/métodos , Bazo/química , Bazo/virología
7.
Presse Med ; 17(33): 1675-8, 1988 Oct 01.
Artículo en Francés | MEDLINE | ID: mdl-2973029

RESUMEN

The toxic effects of 5-fluorouracil - an antimitotic drug widely used in the treatment of cancer - mainly affect the digestive tract and the blood. The 5 new cases presented here may be added to the 57 cases of cardiotoxicity reported in the literature. The clinical manifestations always consist of constrictive chest pain resembling angina pectoris and associated with disorders of repolarization on electrocardiographic tracing recorded during the painful episodes. The outcome is usually favourable after discontinuation of treatment, but it may also be fatal. Reintroduction of the drug in 28 patients resulted in myocardial necrosis in 4 cases and in death due to cardiogenic shock in 4 cases. The frequency of such side-effects does not seem to be influenced by age, sex, route of administration and previous pathology including cardiovascular diseases. They usually occur at the beginning of treatment irrespective of the dose administered. The mechanism through which 5-fluorouracil exerts its cardiotoxic effects is unknown, and 3 hypothesis have been put forward: an immunoallergic reaction after a sensitization period, a coronary spasm directly induced by the drug or due to the release of a vasopressive substance, or a direct toxic effect on the myocardium and pericardium.


Asunto(s)
Fluorouracilo/efectos adversos , Cardiopatías/inducido químicamente , Arritmias Cardíacas/inducido químicamente , Femenino , Cardiopatías/etiología , Humanos , Masculino , Persona de Mediana Edad , Neoplasias/tratamiento farmacológico , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA